Royal Philips

Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment businesses; Connected Care businesses; Personal Health businesses; and Other. The Diagnosis and Treatment businesses segment consists systems, smart devices, software and services, powered by AI-enabled informatics-that support precision diagnoses and minimally invasive procedures in therapeutic areas such as cardiology, peripheral vascular, neurology, surgery, and oncology. The Connected Care businesses segment consists Hospital Patient Monitoring, Emergency Care, Sleep & Respiratory Care and Connected Care Informatics. The Personal Health businesses segment consists of Oral Healthcare, Personal Care,Mother and Child Care. The Other segment reports on the items Innovation & Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment; Connected Care; Personal Health; and Other. The Diagnosis and Treatment segment consists of systems, smart devices, software, and services, powered by AI-enabled solutions that support precision diagnoses and minimally invasive treatment in therapeutic areas such as cardiology, peripheral vascular, neurology, surgery, and oncology. The Connected Care segment focuses on Hospital Patient Monitoring, Sleep and Respiratory Care, and Enterprise Informatics. The Personal Health segment represents Oral Healthcare business unit, Personal Care business unit, and Mother and Child Care business unit. The Other segment is involved on the Innovation and Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.

Leading pathology laboratories deploy tele-diagnostics with Philips during the COVID-19 pandemic

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the publication of the U.S. edition of its Future Health Index (FHI) 2020 report, the first global survey of its kind. Now in its fifth year, the Future Health Index 2020 report – ‘The age of opportunity: Empowering the next generation to transform healthcare' – reveals critical insights from healthcare professionals under the age of 40, a group that will comprise most

Next Generation American Healthcare Professionals Are Among Highest in Workplace Stress in New Global Report

Philips World COPD Day survey reveals care challenges, telehealth adoption, and increased global awareness surrounding respiratory health

Philips continues its top ranking in the Dow Jones Sustainability Indices

Four-year results from patient-level meta-analysis confirm safety profile of Philips Stellarex .035” low-dose drug-coated balloon

Amsterdam, the Netherlands – At the company's virtual Capital Markets Day with investors and financial analysts today, Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, will provide further details of its strategic plan and performance trajectory for the 2021–2025 period. Starting at 13:00 CET / 12:00 GMT / 07:00 EST, Philips CEO Frans van Houten, together with CFO Abhijit Bhattacharya and several executives, will share deeper insights into the company's path to value.

Philips presents its performance and value creation trajectory for the 2021-2025 period at its Capital Markets Day

Philips recognized in Gartner's 2020 Market Guide for Virtual Care Solutions

Philips empowers medical image access for over 5,000 clinicians in the Region of Southern Denmark

Philips to nominate Mrs. Indra Nooyi as member of the Supervisory Board

Philips and Singapore General Hospital (SGH) to establish Digital and Computational Pathology Center of Excellence

SimonMed Imaging partners with Philips to deploy new diagnostic imaging technology to advance radiology workflow performance

Philips and Marienhospital Stuttgart sign 10-year strategic partnership to improve patient care and efficiency

Philips Still Reaping A COVID-19 Tailwind, As Procedure Counts Recover

Koninklijke Philips' (PHG) Q3 top and bottom-line results reflect robust performances in the Connected Care and Personal Health businesses.

Philips' (PHG) Q3 Earnings Up Y/Y on Connected Care Growth

Philips brings advanced digital technology to on-premise e-call systems for senior living owners and operators

Philips provides update on its closing share price on Euronext Amsterdam on October 19, 2020

Koninklijke Philips N.V. (PHG) CEO Frans van Houten on Q3 2020 Results - Earnings Call Transcript

Koninklijke Philips NV (NYSE: PHG), delivered an earnings surprise in the third-quarter 2020 on Monday. Non-GAAP earnings per share of €0.60 beat consensus of €0.46.

Why Philips' Stock Is Trading Higher In Pre-Market Today

Philips N.V. (AMS: PHIA) said its net profit in the fiscal third quarter posted significant growth and topped experts' forecast on Monday.

Philips' net profit jumps to £307 million in the fiscal third quarter

Philips announces Q3 2020 results and provides new financial targets for the 2021–2025 period

DEFINE PCI study one-year data show potential of treating residual ischemia to improve clinical outcomes for coronary stent patients

Philips and Mandaya Royal Hospital Puri sign seven-year partnership agreement to provide patient-centered care

Philips partners with LeQuest to provide online interactive training in ultrasound

Philips expands peripheral vascular disease portfolio with the QuickClear mechanical thrombectomy system for blood clot removal

Tampa General Hospital announces strategic partnership with Philips to innovate and improve patient experience

News for Royal Philips Stock (PHG)